1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Pharmacovigilance and Drug Safety Software Market – By Software Type

1.3.2        Pharmacovigilance and Drug Safety Software Market – By Delivery Mode

1.3.3        Pharmacovigilance and Drug Safety Software Market – By End User

1.3.4        North America Pharmacovigilance and Drug Safety Software Market – By Country

2.           North America Pharmacovigilance and Drug Safety Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Pharmacovigilance and Drug Safety Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Pharmacovigilance and Drug Safety Software Market- North America PEST Analysis

4.3         Expert Opinion

5.           North America Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidences of Adverse Drug Reactions (ADRs)

5.1.2        Globalization of Pharmacovigilance

5.2         Market Restraints

5.2.1        Expensive Technology

5.3         Future Trends

5.3.1        Artificial Intelligence in Pharmacovigilance

5.4         Impact Analysis

6.           Pharmacovigilance and Drug Safety Software Market – North America Analysis

6.1         North America Pharmacovigilance and Drug Safety Software Market Revenue Forecasts and Analysis

7.           North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Software Type

7.1         Overview

7.2         Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

7.3         Adverse Event Reporting Software Market

7.3.1        Overview

7.3.2        Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Drug Safety Audits Software

7.4.1        Overview

7.4.2        Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Issue Tracking Software

7.5.1        Overview

7.5.2        Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Fully Integrated Software

7.6.1        Overview

7.6.2        Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.           North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts To 2027 – By Delivery Mode

8.1         Overview

8.2         Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)

8.3         On-premise

8.3.1        Overview

8.3.2        On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Cloud- Based

8.4.1        Overview

8.4.2        Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9.           North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts to 2027– By End User

9.1         Overview

9.2         Pharmacovigilance (PV) and Drug Safety Software Market, By End User, 2019 & 2027 (%)

9.3         Pharmaceutical and Biotech Companies Market

9.3.1        Overview

9.3.2        Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4         Contract Research Organizations (CROs) Market

9.4.1        Overview

9.4.2        Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Business Process Outsourcing (BPO) Firms Market

9.5.1        Overview

9.5.2        Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1      North America: Pharmacovigilance and Drug Safety Software Market

10.1.1     Overview

10.1.2     North America Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.1.3     US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.1       US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.2       US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.3.3       US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.3.4       US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.4     Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.1       Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.2       Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.4.3       Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.4.4       Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.5     Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.1       Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.2       Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type (US$ Mn)

10.1.5.3       Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.5.4       Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11.        Impact Of COVID-19 Pandemic on North America Pharmacovigilance and Drug Safety Software Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Pharmacovigilance and Drug Safety Software Market

12.3      Organic Developments

12.3.1     Overview

12.3.2     Organic Developments Done by Companies

12.4      Inorganic Developments

12.4.1     Overview

12.4.2     Inorganic Growth Strategies by Companies

13.        COMPANY PROFILES

13.1      Veeva Systems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      IQVIA Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Ennov

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AB Cube

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      United Biosource LLC

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      ArisGlobal LLC

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Sparta Systems

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Oracle Corporation

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Sarjen Systems Pvt. Ltd

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   EXTEDO

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Online Business Applications, Inc.

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 2.             US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 3.             US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 4.             Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 5.             Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 6.             Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 7.             Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 8.             Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 9.             Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 10.          Organic Developments Done by Companies

Table 11.          Recent Inorganic Growth Strategies by the Companies

Table 12.          Glossary of Terms, Pharmacovigilance and Drug Safety Software Market

LIST OF FIGURES

Figure 1.           Pharmacovigilance and Drug Safety Software Market Segmentation

Figure 2.           North America Pharmacovigilance and Drug Safety Software Market Overview

Figure 3.           Adverse Event Reporting Software Segment Held Largest Share of Software Type in Pharmacovigilance and Drug Safety Software Market

Figure 4.           Contract Research Organizations Segment Held Largest Share of End User in Pharmacovigilance and Drug Safety Software Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Pharmacovigilance and Drug Safety Software Market - North America PEST Analysis

Figure 7.           Pharmacovigilance and Drug Safety Software Market Impact Analysis of Driver and Restraints

Figure 8.           North America Pharmacovigilance and Drug Safety Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Pharmacovigilance (PV) and Drug Safety Software Market, by Software Type, 2019 & 2027 (%)

Figure 10.        Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)

Figure 15.        On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Pharmacovigilance (PV) and Drug Safety Software Market, by End User, 2019 & 2027 (%)

Figure 18.        Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        North America Pharmacovigilance and Drug Safety Software Market Revenue Overview, By Country, 2019 (US$ Mn)

Figure 22.        North America Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

Figure 23.        US Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Canada Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 25.        Mexico Pharmacovigilance and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 27.        Growth Strategies in the Pharmacovigilance and Drug Safety Software Market